I had a read through their prospectus, the latest company review and their company presentation, they have been operating at a loss for the past 3 years. Their review mentioned that they hoped to breakeven by some point in 2016 (image attached). Given this information, would you still invest in a company like this, even though their closest competitors do not offer similar products?
Genetic Signatures (GSS) IPO
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.0¢ |
Change
-0.030(4.41%) |
Mkt cap ! $155.4M | |||
| Open | High | Low | Value | Volume |
| 66.0¢ | 66.0¢ | 65.0¢ | $26.35K | 39.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22897 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.0¢ | 56260 | 1 |
View Market Depth
| Last trade - 11.58am 04/12/2024 (20 minute delay) ? |
| GSS (ASX) Chart |
